raubasine has been researched along with harmol in 1 studies
| Studies (raubasine) | Trials (raubasine) | Recent Studies (post-2010) (raubasine) | Studies (harmol) | Trials (harmol) | Recent Studies (post-2010) (harmol) |
|---|---|---|---|---|---|
| 7 | 0 | 3 | 83 | 1 | 16 |
| Protein | Taxonomy | raubasine (IC50) | harmol (IC50) |
|---|---|---|---|
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 44.91 | |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.09 | |
| Serine/threonine-protein kinase haspin | Homo sapiens (human) | 0.77 | |
| Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guengerich, FP; Stöckigt, J; Strobl, GR; von Kruedener, S; Wolff, T | 1 |
1 other study(ies) available for raubasine and harmol
| Article | Year |
|---|---|
Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies.
Topics: Alkaloids; Computer Simulation; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Ethanolamines; Humans; Indoles; Microsomes, Liver; Mixed Function Oxygenases; Models, Molecular; Molecular Conformation; Molecular Structure; Quinidine; Quinolines; Secologanin Tryptamine Alkaloids; Yohimbine | 1993 |